A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer.
| Image |  |
|---|---|
| Description | scientific article published on 6 November 2014 |
| Author/s |
author: John Nemunaitis |
| Publication date | November 6, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |